Planet Labs director Ita M. Brennan sells 11,500 shares

Brennan's reported post-sale holdings included RSUs with quarterly and event-based vesting schedules.

Rhea-AI Filing Summary

Planet Labs PBC director Ita M. Brennan sold 11,500 shares of Class A Common Stock on October 1, 2026, at a weighted average sale price of $16.3025 per share; individual trade prices ranged from $16.15 to $16.58. The sale was made under a Rule 10b5-1 trading plan adopted January 14, 2026. Reported holdings after the sale were 250,373 shares, including RSUs.

Insider Trade Summary 10b5-1

Net Seller: 11,500 shares

Net Sell 1 txn

Insider Brennan Ita M

Role Director

Sold 11,500 shs ($187K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2, F3	11,500	$16.3025	$187K

Holdings After Transaction: Class A Common Stock — 250,373 shares (Direct)

Footnotes (3)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.
2. F2. The sales were executed in multiple trades at prices ranging from $16.15 to $16.58. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3. F3. Includes: (a) 2,052 RSUs that vest in equal quarterly installments on the 15th of December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of the issuer's Class A Common Stock each and have no expiration date.

Key Figures

Shares sold: 11,500 shares Weighted average sale price: $16.3025 per share Sale price range: $16.15 to $16.58 per share +1 more

4 metrics

Shares sold 11,500 shares October 1, 2026

Weighted average sale price $16.3025 per share October 1, 2026 sale

Sale price range $16.15 to $16.58 per share Prices across multiple trades on October 1, 2026

Reported holdings after sale 250,373 shares After the October 1, 2026 transaction; includes RSUs

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, RSUs

3 terms

Rule 10b5-1 trading plan regulatory

"executed pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"reflects the weighted average sale price"

RSUs financial

"2,052 RSUs that vest in equal quarterly installments"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PL shares did Ita M. Brennan sell, and at what price?

Ita M. Brennan sold 11,500 shares of Planet Labs PBC Class A Common Stock on October 1, 2026, at a weighted average sale price of $16.3025 per share; individual sale prices ranged from $16.15 to $16.58.

What RSUs were included in Ita M. Brennan’s reported post-sale holdings at PL?

The reported 250,373-share post-sale position includes 2,052 RSUs vesting in equal quarterly installments on the 15th of December, March and June, and 6,479 RSUs that fully vest on the earlier of the first anniversary of grant or Planet Labs PBC’s next annual meeting of stockholders following the grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 06:10 PM Accepted by SEC EDGAR 10/02/2026 - 06:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brennan Ita M

(Last) (First) (Middle)

C/O PLANET LABS PBC

645 HARRISON STREET, FLOOR 4

(Street)

SAN FRANCISCO CALIFORNIA 94107

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/01/2026		S		11,500(1)	D	$16.3025(2)	250,373(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

2. The sales were executed in multiple trades at prices ranging from $16.15 to $16.58. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

3. Includes: (a) 2,052 RSUs that vest in equal quarterly installments on the 15th of December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of the issuer's Class A Common Stock each and have no expiration date.

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Ita M Brennan	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)